| Thompson Drug South | |
| 975 S Laurel Rd, Ste A, London, Kentucky 40744 | |
| (606) 864-6324 |
| Name | Thompson Drug South |
|---|---|
| Organization Name | Thompson Drug South, Inc. |
| Location | 975 S Laurel Rd, Ste A, London, Kentucky 40744 |
| Type | Supplier |
| Phone | (606) 864-6324 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
ImmunoCellular Therapeutics announced today it has filed an orphan drug application with the U.S. Food and Drug Administration (FDA) for its cancer treatment candidate ICT-107. ICT-107 is a dendritic-cell based cancer vaccine product which targets glioblastoma multiforme (GBM), the most prevalent, aggressive and malignant form of primary brain tumors.
Voalte, the leader in healthcare communication technology, today announced a new capital infusion of $17 million by Ascension Ventures, Cerner Capital, Inc., an affiliate of Cerner Corporation, and Bedford Funding. Series D funding closed on July 27, 2015, bringing the total capital Voalte has raised to nearly $60 million in three years.
The first few days after a cancer diagnosis can feel overwhelming. At the very moment when you must make key decisions about your treatment and care, your brain may feel overloaded processing the distressing news you've just received.
CBSNews.com reports on the development of a dry, inhalable measles vaccine by researchers at the University of Colorado-Boulder (CU-Boulder), who hope that their work will "help pave the way for the inexpensive treatment of a range of other illnesses" (Cooper, 5/5).
› Verified 9 days ago
News Archive
ImmunoCellular Therapeutics announced today it has filed an orphan drug application with the U.S. Food and Drug Administration (FDA) for its cancer treatment candidate ICT-107. ICT-107 is a dendritic-cell based cancer vaccine product which targets glioblastoma multiforme (GBM), the most prevalent, aggressive and malignant form of primary brain tumors.
Voalte, the leader in healthcare communication technology, today announced a new capital infusion of $17 million by Ascension Ventures, Cerner Capital, Inc., an affiliate of Cerner Corporation, and Bedford Funding. Series D funding closed on July 27, 2015, bringing the total capital Voalte has raised to nearly $60 million in three years.
The first few days after a cancer diagnosis can feel overwhelming. At the very moment when you must make key decisions about your treatment and care, your brain may feel overloaded processing the distressing news you've just received.
CBSNews.com reports on the development of a dry, inhalable measles vaccine by researchers at the University of Colorado-Boulder (CU-Boulder), who hope that their work will "help pave the way for the inexpensive treatment of a range of other illnesses" (Cooper, 5/5).
› Verified 9 days ago
20/20 Eyecare Of London, Pllc Type: Medicare Supplier Location: 103 Chera Lynn St, London, Kentucky 40741 Phone: (606) 878-7500 | |
Elite Medical Supply Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1501 S Main St, London, Kentucky 40741 Phone: (606) 330-0570 | |
Huffman And Huffman Psc Type: Medicare Supplier Location: 503 N Main St, London, Kentucky 40741 Phone: (606) 877-1877 | |
Kenney Orthopedics Of London Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 100 London Mountain View Dr, London, Kentucky 40741 Phone: (606) 862-9000 | |
Cvs Pharmacy #06342 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2104 North Main St, London, Kentucky 40741 Phone: (606) 878-7344 |